Introduction tumor lysis syndrome tls is a common, but lifethreatening oncological emergency that frequently requires inpatient management. Tumor lysis syndrome tls describes the clinical and laboratory sequelae that result from the rapid release of intracellular contents of dying cancer cells. With venetoclaxbased treatment, there is a requirement to follow the established guidelines for close monitoring during initiation and ramp up, to reduce the risk of tumor lysis syndrome. Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer. Tumor lysis syndrome tls in adult patients page 1 of 7 disclaimer. The pathophysiology of altered calcium metabolism in rhabdomyolysis induced acute renal failure. Ibrutinib plus venetoclax for the treatment of mantlecell lymphoma. Here, we present a case of stls secondary to a smallcell neuroendocrine tumor of unknown origin in a 66yearold female patient who presented with abdominal discomfort. Acute tumor lysis syndrome in patients with highgrade nonhodgkins lymphoma. Guidelines for the management of pediatric and adult tumor lysis syndrome.
Tumour lysis syndrome symptoms, diagnosis and treatment. Tumor lysis syndrome a 1 tls is a metabolic disorder that results from the rapid. Lusis search methodology was adapted from the scientific search guidelines published in 5. Venetoclax and obinutuzumab in patients with cll and coexisting. A pattern of metabolic derangements occurs as a result of a massive release of intracellular contents into the systemic circulation. It is characterized by hyperuricemia, hyperphosphatemia, hypocalcemia, hyperkalemia and development of uric acid nephropathy, oliguria, acute kidney injury aki and, in severe cases, seizures, cardiac arrhythmias and death. Tumor lysis syndrome, acute kidney injury, acute kidney failure, rasburicase, oncologic emergencies introduction tumor lysis syndrome tls describes the pathological sequela of the rapid lysis of tumor cells. Allopurinol is a structural analog of hypoxanthine and a competitive inhibitor of xanthine oxidase. Everything you need to know about tumor lysis syndrome tl. Tumor lysis syndrome tls is a lifethreatening oncological condition that is typically characterized by metabolic derangements that are often labeled as an acute kidney injury. Pdf steroidinduced tumor lysis syndrome in a patient with. May 10, 2020 tumor lysis syndrome is one important complication that pharmacists should be knowledgeable about as part of the patient care team.
These criteria systems represent progressive revisions of previous laboratory variables. Aug 26, 2020 tumour lysis syndrome tls is an oncological emergency characterised by metabolic and electrolyte abnormalities that can occur after the initiation of any cancer treatment, but can also occur spontaneously. Tls is most frequently a result of cancer treatment in combination with a large tumor burden, but has occasionally been reported to occur spontaneously, especially in cases of. Tumor lysis syndrome is a medical emergency that, without prompt intervention, can result in significant morbidity related to cardiac arrhythmias, seizures, renal failure, and possibly death. It can be diagnosed by its clinical presentation and also by laboratory results. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure, and clinical information. Tumor cytotoxicity releases intracellular contents, including nucleic acids, proteins, and electrolytes into the systemiccirculation and may lead to development of hyperuricemia, hyperphosphatemia, hy. Recognition and management of tumour lysis syndrome tls. Tls is commonly reported in hematological malignancies with rapid cell turnover rates, but is relatively rare in solid tumors.
Tumor lysis syndrome after induction chemotherapy in smallcell lung. To reduce the risk of the tumor lysis syndrome, all patients commenced treatment with ibrutinib. The syndrome consists of laboratory abnormalities either alone laboratory tls or with clinical sequelae including renal failure, seizures, and arrhythmias clinical tls. Acute tumor lysis syndrome in the absence of cytotoxic therapy is an uncommon event but has been reported with hematologic malignancies. Acute kidney injury developed in our patient as a result of the precipitation of uric acid crystals and calcium phosphate crystals and was exacer. Reported incidences of tumor lysis syndrome strati. Hyperphosphatemia may lead to hypocalcemia with resultant tetany or other potentially lifethreatening complications. Nevertheless, a clinician should differentiate tls from other causes of acute kidney injury such as sepsis, obstructive renal disease, medication toxicities including those of chemotherapeutic agentsuse of contrast dye for imaging studies, and rhabdomyolysis, as well as other rarer conditions such as vasculitis and primary glomerulopathies in. Lysis tumor syndrome nejm pdf correction from the new england journal of medicine the tumor lysis syndrome. Given that its prognosis is dismal, it is essential to increase. Tumor lysis syndrome tls is a lifethreatening medical condition that can occur spontaneously or as a complication of cancer therapy for rapidly proliferating and chemosensitive malignancies such as acute lymphoblastic leukemia or highgrade lymphoma. Consensus conference on the management of tumor lysis syndrome. Tumor lysis syndrome tls is a constellation of laboratory and clinical manifestations that can occur spontaneously or after the start of therapy. Cambridge university press, cambridge, pp 709749 4.
Tumor lysis syndrome tls is an important metabolic disorder frequently encountered in the management of a variety of cancers including lymphoma, leukemia, and neuroblastoma. Computed tomography ct abdomen showed a large tumor mass with peritoneal metastasis, and she developed. Correspondence from the new england journal of medicine the tumor lysis syndrome. Tumor lysis syndrome associated with urothelial cancer. Tumor lysis syndrome tls is a serious, sometimes lifethreatening oncologic emergency caused by rapid and massive cellular lysis and subsequent release of tumor cell contents and cytokines into. Tumor lysis syndrome in small cell carcinoma and other solid.
Authors scott c howard 1, deborah p jones, chinghon pui. Feb 17, 2021 tumor lysis syndrome tls is an oncologic emergency that is caused by massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Howard sc, ribeiro rc, pui ch 2006 acute complications. Tumor lysis syndrome and collateral immune activation in. Tumor lysis syndrome american society of nephrology. Tumour lysis syndrome tls is a set of metabolic disorders and a consequence of the rapid release of intracellular components such as potassium, phosphates, nucleic acids, proteins and their metabolites into the bloodstream as a result of the massive destruction of a tumour population.
Rotation prep will no longer be available as part of an individual or institutional subscription to nejm or nejm journal watch. Tumor lysis syndrome tls in adult patients page 2 of 7 disclaimer. Tumour lysis syndrome in patients with chronic lymphocytic. Tumor lysis syndrome tls is an acute, lifethreatening disease among adults and children that is associated with the initiation of cytoreductive therapy in the treatment of malignancy. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure. Tumor lysis syndrome and acute anemia in an african. Preventing and monitoring for tumor lysis syndrome and other. The devastating outcomes of tls arise from rapid tumor cell lysis and the release of metabolites into the systemic circulation, therefore. Acute tumor lysis syndrome after antipd1 immunotherapy nivolumab for metastatic melanoma. For haematological malignancies, targeted therapies, such as small molecule inhibitors and monoclonal antibodies, have a high antitumour activity, are well tolerated, and have a low incidence of associated tumour lysis syndrome. Everything you need to know about tumor lysis syndrome. Tls is an oncologic emergency caused by the rapid and massive breakdown of tumor cells, either spontaneously or after the initiation of cytoreductive therapy. Tumor lysis syndrome tls is an oncologic emergency characterized by lifethreatening metabolic disturbances.
Ards associated with tumor lysis syndrome in a patient. We would like to report an additional case recently seen in our facility. A subscription is required to access all the content in best practice. The shift of potassium, phosphorus, and nucleic acid material into the extracellular space can rapidly overcome existing ho. In some patients, tumor lysis results in acute renal failure. Nov 20, 2020 tumor lysis syndrome is a clinical condition that can occur spontaneously or after initiation of chemotherapyassociated with the following metabolic disorders.
Spontaneous tumor lysis syndrome secondary to smallcell. Tumor lysis syndrome in nonhematologic malignancies. Prevention and management of tumor lysis syndrome in. Josephs hospital and medical center, phoenix, az, usa accepted on 27 february, 2017. Tls comprises laboratory derangements hyperuricaemia, hyperkalaemia, hyperphosphataemia, and hypocalcaemia responsible for acute kidney injury. Tumor lysis syndrome refers to the metabolic disturbances hyperuricemia, hyperphosphatemia, hyperkalemia, and hypocalcemia associated with lymphoproliferative malignancies which occur secondary to cell lysis. It typically occurs in patients with lymphoproliferative malignancies who are exposed to chemotherapy, radiation, or corticosteroids, but can occur spontaneously in the absence of treatment. Daniel brunnhoelzl1 and jue wang 1creighton university school of medicine at st.
Ards developed in association with tumor lysis syndrome tls in a patient with nonhodgkins lymphoma. Tumor lysis syndrome tls is a hematologic emergency caused by massive lysis of tumor cells into the blood stream. Tumor lysis syndrome tls is a lifethreatening medical condition that can occur spontaneously or as a complication of cancer therapy for rapidly proliferating and chemosensitive malignancies. The tumor lysis syndrome nejm new england journal of. Correction from the new england journal of medicine the tumor lysis syndrome. Tumor lysis syndrome tls was first described in 1929 by bedrna and polcak in patients with chronic leukemia. It is the single most common oncologic emergency and a frequent source of inpatient consultation for nephrologists.
Tumor lysis syndrome tls is a potential emergent complication of oncologic treatment. Tumor lysis syndrome and metastatic melanoma springerlink. Although the vast majority of tls is associated with rapidly proliferating hematologic malignancies, it is often overlooked in solid tumor cases and has only been rarely associated with urothelial carcinomas. It is necessary to mention that phosphate binders may be used in patients with hyperphosphatemia in the tls setting. Tumor lysis syndrome after treatment with docetaxel for nonsmallcell lung cancer. Describe the pathophysiology of tumour lysis syndrome. Clinical tumor lysis syndrome is present when laboratory tumor lysis syndrome is accompanied by an increased. Tumor lysis syndrome tls in pediatric patients page 1 of 6. The dose of oral allopurinol for tumor lysis syndrome. Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer, where large amounts of tumor cells are killed off at the same time by the treatment, releasing their contents into the bloodstream. Josephs hospital and medical center, phoenix, az, usa 2university of arizona cancer center at dignity health st. The case described below illustrates spontaneous tumor lysis syndrome in the context of a rapidly proliferating metastatic colonic adenocarcinoma. A case of tumor lysis syndrome induced by surgery in colon.
Although a number of lifethreatening complications have been noted to occur following tls, this appears to be the first report of ards developing in association with tls. In the middle column of table 1 page 1846, the value for ionized calcium in the hypocalcemia row should have been tumor lysis syndrome tls is a constellation of metabolicabnormalitiesresultingfromeitherspontaneousorchemotherapyinducedtumorcelldeath. Tumor lysis syndrome tls, a potential complication of cancer treat ment, occurs. Howard sc, jones dp, pui ch 2011 the tumor lysis syndrome. A pattern of metabolic derangements occurs as a result of a massive release of intracellular contents. Tumour lysis syndrome is a complication of chemotherapy for haematological malignancies.
Tumor lysis syndrome is a massive lysis of malignant cells due to quick proliferation, and it is characterized by hyperuricemia, hyperkalemia, and hyperphosphatemia. The recent advancement in cancer treatment has led to the mounting rate of tls in solid tumors that were previously rarely linked to this complication. Tumor lysis syndrome tls is a constellation of metabolic abnormalities resulting from either spon taneous or chemotherapyinduced tumor cell death. Tls occurs because of the rapid lysis of proliferating tumor cells. The patient was a 55yearold black man with chronic lymphocytic leukemia in whom the tumor lysis syndrome developed after rituximab and bendamustine treatment despite saline and allopurinol.
Pdf diagnosis and management of tumor lysis syndrome. Usually occurs in patients with bulky, rapidly proliferating, and. Practical management of tumour lysis syndrome in venetoclax. Tls is characterized by the release of potassium, phosphorous, and nucleic acids from cancer cells into the blood stream, with the potential to cause hyperkalemia. Jan 25, 2021 correction from the new england journal of medicine the tumor lysis syndrome. The syndrome is deemed spontaneous when it occurs before initiation of any cytotoxic or definitive treatment. Tumor lysis syndrome slt is a rare and potentially fatal entity. Clinical trial evidence has demonstrated that when the dose escalation and risk management protocol for tls is used, there is a low incidence of tls in patients treated with venetoclax, and that these patients can be robustly managed and their tls. With increased availability of highly effective cytotoxic thera. The tumor lysis syndrome occurs when tumor cells release their contents into the bloodstream, either spontaneously or in response to therapy. Tumor lysis syndrome tls is an oncologic emergency with limited treatment options. The nature and severity of the metabolic alterations are variable and may be influenced by the timing and intensity of. Tumor lysis syndrome and acute anemia in an africanamerican. We recently admitted a patient to our intensive care unit with methemoglobinemia and severe hemolytic anemia after he received.
These systems identified variables to define laboratory indications of tumour lysis syndrome, in which metabolic and electrolyte alterations are observed without any clinical symptoms, and clinical tumour lysis syndrome, in which the laboratory alterations are severe enough to produce clinical manifestations, most notably affecting renal, cardiac, and neuromuscular systems. Tumour lysis syndrome is an oncological emergency whereby the lysis or breakdown of vast numbers of cells leads to the release of their contents, which can. Here, we report the rare case of a 70year old man with colon cancer and extensive liver involvement manifesting with tls following surgery. Aug 23, 2018 the tumor lysis syndrome is the most common diseaserelated emergency in children and adults with hematologic cancers. Choose one of the access methods below or take a look at our subscribe or free trial options. Tumour lysis syndrome tls is a lifethreatening emergency characterised by a massive cytolysis with the release of intracellular electrolytes, nucleic acids, and metabolites into the circulation.
Spontaneous tumor lysis syndrome in a patient with newly. Spontaneous tumor lysis syndrome stls, in the absence of prior chemo or radiation therapy, is rare with solid tumors. The tumor lysis syndrome is the most common diseaserelated emergency in children and adults with hematologic cancers. Tumor lysis syndrome is a potentially life threatening complication of massive cellular lysis in cancers. Tumour lysis syndrome tls is a significant complication of haematologic malignancies and their management. Tumor lysis syndrome tls is a lifethreatening oncologic emergency that results from the rapid cytolysis of tumor cells. Tumor lysis syndrome tls is a well described oncologic emergency. Tumor lysis syndrome tls is a potentially lifethreatening metabolic disorder that occurs when tumor cells undergo rapid decomposition spontaneously or in response to cytoreductive therapy.
Department of clinical effectiveness v3 approved by the executive committee of the medical staff on 01192021 tumor lysis syndrome tls in adult patients page 2 of 7 disclaimer. Background tumor lysis syndrome tls results from massive lysis of rapidly proliferating malignant cells, and is characterized by hyperuricemia, hyperkalemia, and hyperphosphatemia. Tumor lysis syndrome tls in adult patients page 1 of 7. Catabolism of the nucleic acids to uric acid leads to hyperuricemia, and the marked increase in uric acid excretion can result in the precipitation of uric acid in the renal tubules and can also induce renal vasoconstriction, impaired autoregulation, decreased renal blood flow, and.
1137 1582 728 653 1265 324 1725 1591 1545 496 1148 1387 1566 721 178 1508 979 1092 1336 925 396 690 428 320 1395 1659 264 1472 1178 488 891 574 49 178 386 1603 1468 1318 729